Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × The Diagnosis Was ALK Positive NSCLC × ensartinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Wilms Tumor 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Central Nervous System Neoplasms 2 Xanthogranuloma, Juvenile 1 The Diagnosis Was ALK Positive NSCLC 1 Solid Tumors 1 Sarcoma, Ewing 1 Melanoma 1 Histiocytic Sarcoma 1 Brain Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05178511 2022-01-05

ERSGATR

Sun Yat-sen University

Phase 2 Unknown

The Diagnosis Was ALK Positive NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡